• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio

    Frontage Bolsters Clinical Services Capabilities

    Sanofi Unveils EUROAPI as Name of New European API Company

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza

    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

    LSNE Expands Fill Finish and Lyophilization Ops
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Virtual Clinical Trials: The Future of Dermatology Studies

    Frontage Bolsters Clinical Services Capabilities

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics

    The Wasdell Group Earns ISO 13485 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Emergent BioSolutions

    Adare Pharma Solutions

    Alcami

    Aphena Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Flow Sciences

    Emergent BioSolutions

    Aphena Pharma Solutions

    PCI Pharma Services

    Cytovance Biologics
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Sanofi and Exscientia Pen €250M Drug Discovery Deal

    Initiates collaboration to develop bispecific-small-molecule drugs

    Sanofi and Exscientia Pen €250M Drug Discovery Deal
    Related CONTENT
    • Sanofi Unveils EUROAPI as Name of New European API Company
    • Irisys Receives NIH Contract for the Formulation of Drinabant
    • Colorcon Ventures Invests in i20 Therapeutics
    • Frontida BioPharma Appoints EVP Technology
    • Sanofi to Acquire Kiadis for $359M
    05.09.17
    Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, has entered a strategic research collaboration and license option agreement with Sanofi in the area of metabolic disease.

    According to Exscientia, delivery of new therapies for metabolic disease, such as diabetes, is hampered by a paucity of single targets that are amenable to drug discovery. To address this challenge, it says it will apply its unique platform to identify and validate combinations of drug targets that could work synergistically and be amenable to its bispecific-small-molecule design strategy—where a small molecule is designed to be compatible with two distinct drug targets.

    Starting with over a thousand disease-relevant target combinations, Exscientia will triage opportunities and prioritize those with promising bispecific binding potential. Target pairs fulfilling these initial tractability criteria will pass through to Exscientia's lead-finding platform in order to generate bispecific-small-molecule compounds that can further validate the biological hypothesis. Bispecific small molecules passing all these quality gates may progress to full candidate delivery projects for Sanofi.

    As part of this agreement, Exscientia will be responsible for all compound design, while chemistry synthesis will be delivered by Sanofi. Further assays, preclinical experiments and subsequent trials for compounds progressing to the clinic will be managed by Sanofi, where Sanofi exercises the license option.

    The commercial terms for this agreement include the payment of research funding in order to identify those target pairs with the best combination of chemical compatibility and strong biological relevance plus further funding for prioritized candidate delivery opportunities. For compounds reaching agreed delivery criteria, a series of milestones covering both non-clinical and clinical may be payable by Sanofi. Finally, any licensed products reaching the market will qualify for recurrent sales milestones. The total amount potentially payable by Sanofi to Exscientia on achieving these milestones is €250 million.

    "We are delighted that Sanofi is engaging with Exscientia in a comprehensive, end-to-end drug discovery project,” said Andrew Hopkins, chief executive officer, Exscientia. “This agreement highlights Exscientia's ability to apply bispecific drug design in a comprehensive and highly productive manner. Sanofi has put together an excellent experimental backbone for this collaboration and we look forward to delivering high-value projects for the company."
    Related Searches
    • discovery
    • sanofi
    • end-to-end
    • Preclinical
    Suggested For You
    Sanofi Unveils EUROAPI as Name of New European API Company Sanofi Unveils EUROAPI as Name of New European API Company
    Irisys Receives NIH Contract for the Formulation of Drinabant Irisys Receives NIH Contract for the Formulation of Drinabant
    Colorcon Ventures Invests in i20 Therapeutics Colorcon Ventures Invests in i20 Therapeutics
    Frontida BioPharma Appoints EVP Technology Frontida BioPharma Appoints EVP Technology
    Sanofi to Acquire Kiadis for $359M Sanofi to Acquire Kiadis for $359M
    Overcoming Preclinical Drug Development Hurdles Overcoming Preclinical Drug Development Hurdles
    Aptuit Names Head of of R&D Ops Aptuit Names Head of of R&D Ops
    China FDA Accepts JHL China FDA Accepts JHL's First Clinical Trial Application
    Evotec Achieves Sanofi Diabetes Milestone  Evotec Achieves Sanofi Diabetes Milestone
    Charles River, Chiesi Extend Drug Discovery Alliance Charles River, Chiesi Extend Drug Discovery Alliance
    Generic Drug Trends Generic Drug Trends
    Sanofi and Lonza in $285mn Biologics Pact Sanofi and Lonza in $285mn Biologics Pact
    Sanofi, MedImmune in RSV Alliance Sanofi, MedImmune in RSV Alliance
    Selexis Inks Agreement With Sanofi Selexis Inks Agreement With Sanofi
    AMRI in Drug Discovery Alliance AMRI in Drug Discovery Alliance

    Related Breaking News

    • Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
      EVOQ Therapeutics and Amgen Partner

      EVOQ Therapeutics and Amgen Partner

      Collaborate on the discovery and development of novel drugs for autoimmune disorders.
      Contract Pharma Staff 01.13.21

    • Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
      Almac Sciences Secures Support from Invest NI

      Almac Sciences Secures Support from Invest NI

      Accelerates enzyme discovery program.
      Contract Pharma Staff 01.13.21

    • Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
      Mogrify Enters Research Collaboration with MRC LMB

      Mogrify Enters Research Collaboration with MRC LMB

      Research project aims to develop novel protein expression systems via cell reprogramming.
      Contract Pharma Staff 01.11.21


    • Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
      Servier and X-Chem Enter Drug Discovery Collaboration

      Servier and X-Chem Enter Drug Discovery Collaboration

      Partner to identify and develop novel small molecules for the treatment of neurological disorders.
      Contract Pharma Staff 01.07.21

    • Breaking News | CRO News | Drug Discovery | Preclinical Outsourcing
      Charles River Labs Acquires Distributed Bio

      Charles River Labs Acquires Distributed Bio

      Establishes integrated, large molecule discovery platform.
      Contract Pharma Staff 01.04.21

    • Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
      Evotec, BMS Advance Targeted Protein Degradation Projects

      Evotec, BMS Advance Targeted Protein Degradation Projects

      The first two targets transition into drug discovery after completing a comprehensive target validation process.
      Contract Pharma Staff 12.17.20


    • Breaking News | Collaborations & Alliances | CRO News | Drug Discovery | Industry News | R&D
      Evotec and Sartorius Partner with Curexsys

      Evotec and Sartorius Partner with Curexsys

      Leverage IPSC platform for scalable manufacturing of Curexsys' exosome-based therapeutics.
      Contract Pharma Staff 12.09.20

    • Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
      Syngene and 3DC Sign 5-year Collaboration

      Syngene and 3DC Sign 5-year Collaboration

      Partner on discovery projects, from target validation through to pharmacological proof of concept and preclinical evaluation.
      Contract Pharma Staff 11.24.20

    • Breaking News | CRO News | Drug Discovery | Industry News
      MercachemSyncom Acquires Admescope

      MercachemSyncom Acquires Admescope

      Significantly expands its capabilities for in vitro and in vivo studies.
      Contract Pharma Staff 11.10.20


    • Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
      Eurofins Discovery Collaborates with Swiss Biotech Amphilix

      Eurofins Discovery Collaborates with Swiss Biotech Amphilix

      To support a program aimed at identifying a treatment modulating key disease mechanisms.
      Contract Pharma Staff 11.03.20

    • Analytical Services | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News
      Thermo Fisher, Symphogen Extend Development Pact

      Thermo Fisher, Symphogen Extend Development Pact

      Will support the development of cancer treatments through optimization of protein characterization and quality monitoring mass spectrometry.
      Contract Pharma Staff 10.29.20

    • Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News
      ImmunOs Uses ProBioGen’s Pathway Modulator Technology

      ImmunOs Uses ProBioGen’s Pathway Modulator Technology

      DirectedLuck transposase technology will be used to increase protein yield of selected candidates in their pipeline of complex recombinant proteins.
      Contract Pharma Staff 10.27.20


    • Bio News | Bioanalytical Services | Bioassay Development | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
      Axxam and Fujifilm Cellular Dynamics Enter Alliance

      Axxam and Fujifilm Cellular Dynamics Enter Alliance

      Partner to deliver integrated hiPSC drug discovery solutions.
      Contract Pharma Staff 10.08.20

    • Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | Preclinical Outsourcing
      Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200

      Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200

      Paves the way towards getting OCU200 in the clinic by first half of 2022.
      Contract Pharma Staff 10.06.20

    • Breaking News | cGMP Manufacture | Clinical Trials | Drug Development | Drug Discovery | Industry News
      BioDuro, Sundia Partner as New CRDMO

      BioDuro, Sundia Partner as New CRDMO

      Advent International investment creates services company with over 2,000 employees and 10 facilities in China and U.S.
      Contract Pharma Staff 09.25.20

    Trending
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Baxter, Novavax Ink Sterile Manufacturing Agreement
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    • A New Era Of Vaccine And Biologic Drug Development
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    Breaking News
    • KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    • Frontage Bolsters Clinical Services Capabilities
    • Sanofi Unveils EUROAPI as Name of New European API Company
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Precision Medicine Group Acquires Project Farma
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Brown Fat Associated with Reductions in Chronic Disease Risk
    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    P&G, L'Oréal & Amorepacific Make News at CES
    Three Form Vertical Beauty Alliance
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login